Business Name: |
Guevarra Andres T MD |
Contact Person: |
Andres Guevarra |
Address: |
212 West Route 38 # 400, Moorestown, New Jersey 08057 |
Phone Number: |
(856) 235-0264 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Klingenstein Gregory G MD - Moorestown, NJ 08057 Mark R Zaontz Md - Moorestown, NJ 08057 Borra Gayatri MD - Moorestown, NJ 08057 Kirschner-Levy Stacy MD - Moorestown, NJ 08057 Larkin Joyce M MD - Moorestown, NJ 08057 Levin Irina MD - Moorestown, NJ 08057 David's On Main - Moorestown, NJ 08057 Levin Sanan L MD - Moorestown, NJ 08057 Schoifet Scott D MD - Moorestown, NJ 08057 Wexler Amy R MD - Moorestown, NJ 08057 Guevarra Jesusita H MD - Moorestown, NJ 08057 Putnam Daniel MD - Moorestown, NJ 08057 Peterson Dolores MD - Moorestown, NJ 08057 Kimmel Craig S MD - Moorestown, NJ 08057 Baskies Arnold M MD - Moorestown, NJ 08057 Schaffzin Lawrence S MD - Moorestown, NJ 08057 Chung Kyu M MD - Moorestown, NJ 08057 Summersgill R Blair MD - Moorestown, NJ 08057 Lma Endocrinology Assoc - Moorestown, NJ 08057 Stackhouse Thomas G MD - Moorestown, NJ 08057 |
The company Guevarra Andres T MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Guevarra Andres T MD, and the business now earns $500.000 to $999.999 per annum.
Guevarra Andres T MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Guevarra Andres T MD, please call Andres Guevarra with the phone number (856) 235-0264 or visit its single location at 212 West Route 38 # 400 in Moorestown, New Jersey 08057.
The location of the single location can also be found using the coordinates 39.9541,-74.947533.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.